JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 12 1910-1915
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okazawa, H.
Right arrow Articles by Konishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okazawa, H.
Right arrow Articles by Konishi, J.

Clinical Application and Quantitative Evaluation of Generator-Produced Copper-62-PTSM as a Brain Perfusion Tracer for PET

Hidehiko Okazawa, Yoshiharu Yonekura, Yasuhisa Fujibayashi, Sadahiko Nishizawa, Yasuhiro Magata, Koichi Ishizu, Fumiko Tanaka, Tatsuro Tsuchida, Nagara Tamaki and Junji Konishi

Departments of Nuclear Medicine, Brain Pathophysiology and Radiopharmaceutical Chemistry, Kyoto University, Kyoto, Japan

Correspondence: For correspondence or reprints contact: Hidehiko Okazawa, MD, Department of Nuclear Medicine, Kyoto University School of Medicine, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto 606-01, Japan.

ABSTRACT

Copper-62-pyruvaldehyde bis(N4-methylthiosemicarbazone) copper II (62Cu-PTSM) has been proposed as a generator-produced positron-emitting tracer for perfusion imaging. To evaluate the characteristics of 62Cu-PTSM as a cerebral perfusion tracer, brain PET images of 62Cu-PTSM were compared with cerebral blood flow (CBF). Methods: Following an intravenous injection of 62Cu-PTSM, a serial dynamic PET scan was performed for 10 min with arterial sampling in 10 subjects. CBF was measured by 15O-labeled water before the 62Cu-PTSM study. Results: Dynamic PET scan with octanol-extracted arterial input function indicated the presence of significant back-diffusion of 62Cu-PTSM from the brain within 3 min after injection, followed by stable activity from 3 to 10 min. Comparison with 15O-water PET demonstrated less contrast between high- and low-flow regions in 62Cu-PTSM image and a nonlinear relationship of flow and 62Cu-PTSM uptake, which suggests the underestimation of CBF in high-flow regions due to the existence of back-diffusion. Conclusion: Although 62Cu-PTSM can be used widely for evaluation of brain perfusion with PET, kinetic analysis and correction may be needed to quantify regional CBF.

Key Words: copper-62-PTSM • PET • cerebral blood flow • perfusion tracer




This article has been cited by other articles:


Home page
JNMHome page
H. Okazawa and M. Vafaee
Effect of Vascular Radioactivity on Regional Values of Cerebral Blood Flow: Evaluation of Methods for H215O PET to Distinguish Cerebral Perfusion from Blood Volume
J. Nucl. Med., July 1, 2001; 42(7): 1032 - 1039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.